Relationship of age, gender, race, and body size to infrarenal aortic diameter  by Lederle, Frank A. et al.
Relationship of age, gender, 
body size to infrarenal aortic 
race, and 
diameter 
Frank  A.  Leder le ,  MD,  Gary  R. Johnson ,  MS,  Samuel  E. Wi l son ,  MD,  
Ian  L. Gordon ,  MD,  Edmund P. Chute ,  MD,  F red  N.  L i t tooy ,  MD,  
Wi l l i am C. Krupsk i ,  MD,  Denn is  Bandyk ,  MD,  Gary  W.  Barone ,  MD,  
L inda  M.  Graham,  MD,  Rober t  J. Hye ,  MD,  Donovan B. Re inke,  MD,  
and  the  Aneurysm Detect ion  and  Management  (ADAM)  Veterans  Affairs 
Cooperat ive  S tudy  Invest igators*  
Purpose: To assess the effects of  age, gender, race, and body size on infrarenal aortic 
diameter ( IAD) and to determine xpected values for IAD on the basis of  these factors. 
Methods: Veterans aged 50 to 79 years at 15 Department of  Veterans Affairs medical 
centers were invited to undergo ultrasound measurement of IAD and complete a pre- 
screening questionnaire. We report here on 69,905 subjects who had no previous history 
of  abdominal aortic aneurysm (AAA) and no ultrasound evidence of  AAA (defined as 
IAD ----- 3.0 cm). 
Results: Although age, gender, black race, height, weight, body mass index, and body 
surface area were associated with IAD by multivariate linear regression (all p < 0.001), 
the effects were small. Female sex was associated with a 0.14 cm reduction in IAD and 
black race with a 0.01 cm increase in IAD. A 0.1 cm change in IAD was associated with 
large changes in the independent variables: 29 years in age, 19 cm or 40 cm in height, 35 
kg in weight, 11 kg /m 2 in body mass index, and 0.35 m 2 in body surface area. Nearly all 
height-weight groups were within 0.1 cm of  the gender means, and the unadjusted 
gender means differed by only 0.23 cm. The variation among medical centers had more 
influence on IAD than did the combination of  age, gender, race, and body size. 
Conclusions: Age, gender, race, and body size have statistically significant but small effects 
on IAD. Use of  these parameters to define AAA may not offer sufficient advantage over 
simpler definitions (such as an IAD -----3.0 cm) to be warranted. (J Vase Surg 1997; 
26:595-601.) 
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Fig. 1. Distribution of IAD measurements in 73,271 vet- 
erans aged 50 to 79 years. 
infrarenal aortic diameter (IAD) compared with the 
expected IAD based on age, sex, and other factors 
such as body size? However, values for expected 
IAD have not been well defined. Previous tudies of 
the effects of these factors on IAD have included 
relatively small numbers of subjects, and their results 
have often been conflicting. 2-s To assess the effects of 
age, gender, race, and body size on IAD and to 
determine xpected values for IAD on the basis of 
these factors, we analyzed data from a large ultra- 
sound screening program. 
METHODS 
All active patients at 15 Veterans Affairs (VA) 
medical centers who were 50 to 79 years of age were 
invited by mail to undergo ultrasound measurement 
of their aortic diameter as part of the aneurysm de- 
tection and management (ADAM) study. Descrip- 
tions of the ADAbl study, the screening program, 
and the prevalence and associations of AAA found in 
the screening program have been previously report- 
ed. 6,7 The study was approved by the human rights 
Table I. Characteristics of 69,905 veterans 
aged 50 to 79 years with IAD < 3.0 cm 
Characteristic Value * 
Age (yr) 66 + 7 
Male sex 97% 
Race 
White 87% 
Black 8% 
Other 5% 
Height (cm) 176 _+ 7 
Mean weight (kg) 85 _+ 16 
Waist circumference (cm) 96 -+ 11 
Body mass index (kg/m 2) 27 +- 5 
Body surface area (m 2) 2.0 + 0.2 
Infrarenal aortic diameter (cm) 2.0 -+ 0.3 
S uprarenal ortic diameter (cm) 2.1 -+ 0.3 
*Plus-minus values are means -+ SD. 
committee at the VA Cooperative Studies Program 
coordinating center and by the institutional review 
boards at the 15 participating centers. 
The study ultrasonographers used 3.5 MHz real- 
time sector scanners to measure the abdominal aorta 
above and below the renal arteries in the anteropos- 
terior and lateral planes and were instructed to record 
the maximum external diameter in any direction at 
the widest point of  any dilatation for both the supra- 
renal and infrarenal segments. The ultrasonogra- 
phers met twice during the study to review tech- 
niques and compare measurement distributions. 
Subjects who were screened from the beginning of 
the program in October 1992 through March 1995 
are included in this report. 
Age, gender, race, height, weight, and waist cir- 
cumference were recorded in a questionnaire com- 
pleted by all subjects before the ultrasound examina- 
tion. Because we wished to define expected normal 
values for IAD, subjects who had a previous history 
of AAA or who had an AAA detected by ultrasound 
(defined as IAD ->3.0 cm) were excluded from anal- 
ysis. 
The relationships between IAD and age, gender, 
race, and body size were determined by univariate 
and multivariate linear regression using IAD as the 
dependent variable. Three methods of modeling 
body size were considered. The first model was con- 
structcd using the independent variables from the 
questionnaire (height, weight, and waist circumfer- 
ence). In the second model, body mass index [BMI; 
calculated as (weight in kg)/(height in m)2],  a mea- 
sure of obesity, was substituted for weight. In the 
third model, body surface area [BSA; calculated in 
m 2 by the method of DuBois 8 as: 0.007184 (height 
in cm) 0-725 (weight in kg)°42s], a measure of body 
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Table I I .  Multivariate linear regression models o f  IAD in 68,414 veterans aged 50 to 79 years with 
IAD < 3 .0cm 
Factor F test p Slope * 95% CI of slope 
Model 1 (Height Age (per 10 years) 557 <0.001 0.034 
and weight) Female sex (vs male) 512 <0.001 -0.140 
Black race (vs white) 15 <0.001 0.014 
Other ace (vs white) 1 0.30 -0.005 
Waist circumference (per 10 cm) 6 0.I3 0.004 
Height (per 10 cm) , 257 <0.001 0.025 
Weight (per 10 kg) 573 <0.001 0.028 
Medical center 2085 <0.001 
Model 2 (Height Age (per 10 years) 566 <0.001 0.035 
and BMI) Female sex (vs male) 508 <0.001 0.140 
Black race (vs white) 14 <0.001 0.013 
Other race (vs white) 1 0.34 - 0.004 
Waist circumference (per 10 cm) 4 0.06 0.003 
Height (per 10 cm) 117 <0.001 0.053 
BMI (per 10 kg/m 2) 600 <0.001 0.091 
Medical center 2087 <0.001 
Model 3 (BSA) Age (per 10 years) 568 <0.001 0.034 
Female sex (vs male) 552 <0.001 -0.140 
Black race (vs white) 15 <0.001 0.014 
Other race (vs white) 1 0.26 -0.005 
Waist circumference (per 10 cm) 8 0.004 0.004 
BSA (m 2) 1319 <0.001 0.290 
Medical center 2087 <0.001 
0.032, 0.037 
-0.153, -0.I28 
0.007, 0.021 
-0.014, 0.004 
0.001, 0.007 
0.022, 0.028 
0.026, 0.031 
0.032, 
-0.152, 
0.007, 
-0.013, 
0.000, 
0.050, 
0.084, 
0.038 
-0.128 
0.021 
0.005 
0.006 
0.056 
0.098 
0.031, 0.037 
-0.152, -0.129 
0.007, 0.021 
-0.014, 0.004 
0.001, 0.006 
0.274, 0.305 
R 2 = 0.338 for each of the three models. 
*Change in IAD (cm) per unit change in factor. 
C/, Confidence intervals. 
size, was substituted for height and weight. A set o f  
indicator variables to represent the different medical 
centers was also included in the models. Subjects 
with missing responses or extreme values for numer-  
ical responses were deleted from analyses involving 
that response. 
RESULTS 
Dur ing the study period, 320,000 letters were 
mailed out,  o f  which 91,000 were returned by sub- 
jects indicat ing their will ingness to be screened. A 
total o f  73,943 subjects aged 50 to 79 years who did 
not  have a previous history o f  AAA underwent  
screening; 492 o f  them were excluded because the 
aorta could not  be visualized, and 180 were excluded 
because the IAD was recorded only as "less than 3.0 
cm." The distr ibution o f  IAD in the remaining 
73,271 subjects is shown in Fig. 1. After exclusion o f  
3366 subjects who had IADs o f  3.0 cm or greater, 
the remaining 69,905 constitute the study group 
(described in Table I),  o f  whom 68,414 had com- 
plete data for all variables. Though our study group 
was 97% male (Table I), it included 2004 women.  
Table I I  shows the results o f  the three multivari- 
ate linear regression models. Age, gender,  black race, 
height,  weight,  BMI ,  and BSA were significantly 
Tab le  I I I .  Mean IAD by medical center 
Medical center No. of subjects Mean IAD * 
Minneapolis, Minn. 6333 1.7 
Denver, Colo. 4263 1.7 
Tampa, Fla. 4863 1.8 
Milwaukee, Wis. 4138 1.8 
Madison~ Wis. 3568 1.9 
Long Beach, Calif. 5275 1.9 
Ann Arbor, Mich. 3727 2.0 
Miami, Fla. 4481 2.0 
Portland, Ore. 3434 2.0 
Little Rock, Ark. 5286 2.1 
Cleveland, Ohio 4421 2.1 
San Diego, Calif. 6093 2.1 
Chicago, Ill. 4450 2.1 
Richmond, Va. 3662 2.2 
Pittsburgh, Pa. 5911 2.3 
Total 69905 2.0 
*All standard eviations equal 0.2 or 0.3 cm. 
associated with IAD by mult iple l inear regression in 
all three models (all p < 0.001),  but  the effects were 
small. Female sex was associated with a 0.14 cm 
reduct ion in IAD and black race with a 0.01 cm 
increase in IAD. A 0.1 cm increase in IAD was 
associated with large increases in the independent  
variables in the three models: 29 years in age, 40 cm 
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Table IV. Mean IAD by height and weight 
in men 
Table V. Mean lAD by height and weight 
in women 
Height* (cm) Weight (kg) No. of subjects Mean IADt 
150-169 45-64 1732 1.9 120-i49 
65-79 4435 1.9 
80-94 2118 2.0 150-159 
95-119 531 2.1 
->120 51 2.1 
170-179 45-64 2189 1.9 
65-79 12859 2.0 160-169 
80-94 13216 2.0 
95-119 4973 2.0 
>120 518 2.1 
180-189 45-64 612 2.0 ->170 
65-79 4346 2.0 
80-94 9953 2.0 
95-119 6637 2.1 
->120 1001 2.1 Total 
->190 45-64 34 2.0 
65-79 178 2.0 
80-94 649 2.0 
95-119 994 2.1 
->120 274 2.2 
Total 67310 2.0 
*Ten men with height < 150 cm are not included. 
J-All standard deviations equal 0.3 cm. 
(model 1) or 19 cm (model 2) in height, 35 kg in 
weight, 11 kg /m 2 in BMI, and 0.35 m 2 in BSA. 
The three models performed similarly, with each 
model explaining 33.8% of the variability in LAD. 
The majority of this variability was explained by the 
indicator variables for medical center. Models con- 
structed without these medical center variables ex- 
plained only 5.5% of the variability in IAD. Thus 
variation among medical centers had far more influ- 
ence on LAD than did the combination of age, gen- 
der, race, and body size. The unadjusted mean LAD 
at the different medical centers ranged from 1.7 cm 
to 2.3 cm (Table III). 
Because height and weight were no less predic- 
tive of IAD than BMI or BSA and are more conve- 
niently obtained, they were used fop stratification i  
Tables IV and V. The mean IAD ranged from 1.7 cm 
for women less than 170 cm in height and 70 kg in 
weight to 2.2 cm for men 190 cm or more in height 
and 120 kg or more in weight. Apart from this latter 
group (which accounted for only 0.4% of men), all 
the other height-weight groups of men had mean 
IADs within 0.1 cm of the overall mean for men of 
2.0 cm. All height-weight groups of womeri had 
mean IADs within 0.1 cm of the overall mean for 
women of 1.8 cm. 
Several additional linear regression analyses were 
performed to investigate whether our findings were 
sensitive to (1) choice of arterial segment, (2) defini- 
Height (cm) Weight (kg) No. of subjects Mean IAD* 
45-59 20 1.7 
->60 19 1.8 
45-59 153 1.7 
60-69 162 1.7 
70-79 78 1.8 
->80 90 1.8 
45-59 215 1.7 
60-69 321 1.7 
70-79 243 1.8 
->80 312 1.9 
45-59 28 1.8 
60-69 83 1.8 
70-79 88 1.8 
->80 192 1.9 
2004 1.8 
*All standard deviations equal 0.3 cm. 
tion of AAA to be excluded, or (3) inclusion of 
medical conditions. When the analyses hown in Ta- 
ble II were repeated with suprarenal aortic diameter 
substituted for LAD, or with excluded AAA defined 
as a ratio ofinfrarenal to suprarenal ortic diameter of 
->1.5 instead of as LAD ->3.0 cm, all regression 
coefficients remained similar in magnitude and direc- 
tion. When the analyses hown in Table II were 
repeated with variables from the available medical 
history included (family history of  AAA, history of  
smoking, hypertension, high cholesterol, coronary 
artery disease, claudication, cerebral vascular dis- 
ease, deep venous thrombosis, diabetes mellitus, 
chronic obstructive pulmonary disease, and non- 
skin cancer), none of these variables was associated 
with more than a 0.05 cm change in IAD, and the 
addition of  all these variables increased the ex- 
plained variability of  the IAD by less than 1%. Thus 
our findings were not sensitive to choice of  arterial 
segment, definition of excluded AAA, or inclusion 
of  medical conditions. ° 
DISCUSSION 
In this Study, mean IAD increased with age, male 
gender, black race, and body size, but the effects 
were small and these factors explained very little of 
the variability in IAD. Height and weight were no 
less predictive of IAD than BMI or BSA. Nearly all 
height-weight groups were within 0.1 cm of the 
gender means, and the gender means differed by only 
0.23 cm. These differences were smaller than the 
mean differences that we observed between medical 
centers and approximate the variability reported be- 
tween repeated LAD measurements on the same pa- 
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tient by the same observer under optimal condi- 
tions .9- ~ 
Previous studies involving multivariate analyses 
of the effect of various factors on IAD have reported 
on less than 1000 subjects each. The largest of these 
included 906 men, 2 another involved 307 subjects, 
half of whom were undergoing staging for cancer, a 
and two other studies included 160 and 146 sub- 
jects, respectively. 4,sA larger study of 5283 subjects 
reported unadjusted effects of age and gender on 
IAD.  12 
MI five of these studies reported an increase in 
lAD with age. No continuous relationship between 
age and IAD was apparent in the study of 906 men, 13 
but a significant difference between the older and 
younger halves of the population was subsequently 
reported. 2 The three studies that quantified the in- 
crease in IAD with age reported effects that, though 
somewhat larger than those observed in our study, 
were still quite small (0.05 to 0.07 cm of lAD per 10 
years of age).3,4,12 
Of  the three previous tudies to include gender in 
a multivariate analysis, one found no effect of gender 
on IAD after adjustment for body size and other 
variables, 5 and another did not report he magnitude 
of the effect observed. 4 In the third study, athe effect 
of gender on IAD after adjustment for body size and 
other variables was 0.26 cm, compared with 0.14 cm 
in our study. The unadjusted ifference between 
gendcr means has been reported as 0.23 cm and 0.35 
cm by others, 4,12 and was 0.23 cm in our study. 
The four previous multivariate analyses of the 
etthct of body size on IAD obtaincd inconsistent 
results. One reported no association of IAD with 
height or weight after adjustment for other vari- 
ables, 4two reported an association with BSA but not 
with height or weight, a,s and the fourth reported an 
association with height but not with weight, BSA, or 
BMI. 2 Taken together, these findings are consistent 
with our finding of statistically significant but small 
ettkcts for all of these variables. 
The factor most strongly associated with IAD in 
our study was the medical center. The influencc of 
medical center on LAD was presumably mediated 
through local differences in either study population 
(though Table III does not suggest strong regional 
trends) or, more likely, in ultrasound measurement 
technique. Any differences in measurement tech- 
nique occurred despitc our uniform definition of  
IAD and the two meetings of our ultrasonographers. 
Larger differences could therefore be expected in 
usual practice. In any case, our observation that the 
medical center was more closely associated with IAD 
than were age, gender, race, and body size casts 
further doubt on the utility of adjusting the normal 
range of IAD using these parameters. 
The large size of our study greatly reduces the 
risk, common to all previous studies, of overfitting 
the multivariate model to the peculiarities of a small 
sample that is not representative of the general pop- 
ulation. It also ensured an adequate number of sub- 
jects in each height-weight subgroup. A potential 
limitation related to the size of  our study is that data 
accuracy may be less than in a small study conducted 
under carefully controlled conditions. One possible 
indication of inaccuracy is the variation among med- 
ical centers discussed in the preceding paragraph. 
Another possible indication of inaccuracy in ultra- 
sound measurements is the degree of terminal digit 
preference or "rounding off." Comparison of Fig. 1 
with computed tomogram (CT) readings previously 
published by our group n shows that the IAD mea- 
surements in the present study exhibit more digit 
preference than the central CT readings in the earlier 
study (which represented a research setting) but con- 
siderably less digit preference than the local CT read- 
ings (which more nearly represented a practice set- 
ting). 
Another possible source of inaccuracy in our 
study was the subjects' self-reporting of age, sex, 
race, and body size. We have previously compared 
data from this questionnaire in screened patients who 
were found to have AAA and later enrolled in the 
clinical trial with data collected by study nurses on 
the basis of interview and chart review. This compar- 
ison demonstrated essentially perfect agreement on 
sex and race, a 95% likelihood of being within 3.6 
years on age, and good agreement on body size. 7 
Age, gender, race, and body size have statistically 
significant but small effects on IAD. Use of  these 
parameters to define AAA may not offer sufficient 
advantage over simpler definitions (such as an lAD 
->3.0 cm) to be warranted. 
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